Share This Link

Cervical dilation of 3 cm is a standard clinical requirement for the safe and successful placement of an FSE. While the membranes must be ruptured, this finding indicates the cervix is sufficiently open to allow for procedure access.

A vertex presentation with the fetal head well applied to the cervix is the ideal position for electrode placement. This finding confirms that the presenting part is accessible, making the procedure technically feasible and safe to perform.

Clear amniotic fluid is a normal clinical finding and does not impact the safety or advisability of the procedure. Absence of meconium suggests that the fetus is not currently experiencing meconium staining, which is not a factor in FSE placement.

Notifying the provider of a normal finding is unnecessary and wastes clinical time. The nurse must be able to distinguish between normal physiologic measurements and those that indicate potential complications, such as uterine hypertonus.

Repositioning the catheter is not indicated because the device is functioning correctly and providing a valid reading. This action would cause unnecessary discomfort to the client and disrupt the continuity of the data being collected.

Amnioinfusion is a treatment for repetitive variable decelerations or thick meconium, not for a normal resting tone. This procedure is inappropriate in this context and would be considered an unnecessary invasive intervention.

Discontinuing oxytocin is only indicated for uterine tachysystole or fetal distress. This finding shows hypotonic labor, not hyperstimulation, so stopping the infusion would unnecessarily arrest the progress of labor at this stage.

Simply documenting and continuing routine monitoring is insufficient because the client is not achieving the necessary labor progress. The nurse must actively facilitate the augmentation protocol as ordered to ensure that the birth process remains moving forward.

An emergency cesarean birth is only indicated for fetal compromise or maternal instability. A low MVU calculation is a common clinical finding that requires pharmacologic titration rather than surgical intervention, assuming the fetal heart rate remains reassuring.

Increased frequency of contractions is not a desired outcome and may indicate uterine hypertonus. Excessive uterine activity is a potential complication of amnioinfusion that could lead to fetal distress or compromised perfusion, requiring immediate reassessment.

Pelvic pressure is a normal sensation during the descent of the fetus in labor. It is not an indicator that the amnioinfusion therapy has successfully addressed the underlying issue of umbilical cord compression or fetal distress.

Clear fluid return confirms the absence of meconium but does not assess the success of the fetal heart rate stabilization. The return of fluid is a technical aspect of the procedure, not a marker of therapeutic effectiveness regarding oxygenation.

Mild erythema is a common finding following the attachment of a scalp electrode due to the localized pressure. It is typically a transient response that resolves on its own and does not indicate an infectious process.

A small superficial abrasion is a minor skin injury resulting from the mechanical attachment of the electrode. It is considered an expected, non-threatening result of invasive monitoring and does not require provider notification.

A slight residual imprint is a normal result of the spiral electrode being secured to the scalp. This mark is purely mechanical in nature and will fade naturally as the skin recovers, requiring no specific medical follow-up.

Intact membranes are a contraindication for invasive monitoring, as placement requires artificial rupture. The client is not currently a candidate for an IUPC until the amniotic sac has been ruptured, either spontaneously or by the provider.

A footling breech presentation with an unengaged head is a major contraindication for invasive monitoring. The device could cause fetal injury, and the risk of prolapsed cord is significantly increased with invasive procedures in this presentation.

Placenta previa is an absolute contraindication for any invasive monitoring, including IUPC placement. The insertion could cause severe hemorrhage by damaging the placental tissue, which lies over or near the internal cervical os.

A cervical dilation of 4 cm is well beyond the minimum requirement of 2 cm for safe IUPC insertion. This finding confirms the client has met the anatomical criteria necessary to proceed with the instrumentation safely.

Spontaneous rupture of membranes is a necessary prerequisite for the placement of any internal monitoring device. Clear amniotic fluid is a reassuring finding that indicates the patient is technically cleared for the procedure.

Epidural anesthesia does not interfere with the insertion of an intrauterine pressure catheter. As long as the patient is hemodynamically stable, the presence of an epidural is irrelevant to the procedural safety of placing the internal monitoring device.